TI
NAMS icon

Tidal Investments’s NewAmsterdam Pharma NAMS Stock Holding History

Tidal Investments’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
19,800
-2,600
-12% -$85.7K ﹤0.01% 1946
2026
Q1 		$717K Buy
22,400
+20,000
+833% +$651K ﹤0.01% 1667
2025
Q4 		$84.2K Buy
+2,400
New +$87.3K ﹤0.01% 2080

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Tidal Investments's NAMS Position: Q2 2026 in Review

Tidal Investments reduced its NewAmsterdam Pharma (NAMS) stake by 11% in Q2 2026, selling an estimated $84.5K and leaving 19,894 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

Tidal Investments first reported a position in NAMS in Q1 2026 and has held it in 2 quarters since. The position peaked at $719K in Q1 2026. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Tidal Investments held 19,894 shares of NewAmsterdam Pharma worth $674K as of Q2 2026.
  • Tidal Investments sold 2,564 NewAmsterdam Pharma shares in Q2 2026, an estimated $84.5K.
  • NewAmsterdam Pharma made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1944 holding.
  • Tidal Investments first reported a position in NewAmsterdam Pharma in Q1 2026 and has held it in 2 quarters since.
  • Tidal Investments's NewAmsterdam Pharma position peaked at $719K in Q1 2026.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.